A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://pubmed.ncbi.nlm.nih.gov/36973046/ below:

Proactive Recruitment Strategy for Patient Identification for Lung Cancer Screening

. 2023 Mar-Apr;21(2):119-124. doi: 10.1370/afm.2905. Proactive Recruitment Strategy for Patient Identification for Lung Cancer Screening

Affiliations

Affiliations

Item in Clipboard

Proactive Recruitment Strategy for Patient Identification for Lung Cancer Screening

Sowmyanarayanan Thuppal et al. Ann Fam Med. 2023 Mar-Apr.

. 2023 Mar-Apr;21(2):119-124. doi: 10.1370/afm.2905. Authors Sowmyanarayanan Thuppal  1   2 Jared R Hendren  1 Joni Colle  1 Amit Sapra  3 Priyanka Bhandari  3 Rachel Rahman  3 Amanda Krus-Johnston  3 M Rebecca Hoffman  3 Nathalie Foray  4 Stephen Hazelrigg  1 Traves Crabtree  5 Affiliations

Item in Clipboard

Abstract

Purpose: We assessed low-dose computed tomography (LDCT) screening for lung cancer using a proactive patient education/recruitment program.

Methods: We identified patients aged 55-80 years from a family medicine group. In the retrospective phase (March-August, 2019), patients were categorized as current/former/never smokers, and screening eligibility was determined. Patients who underwent LDCT in the past year, along with outcomes, were documented. In the prospective phase (2020), patients in the same cohort who did not undergo LDCT were proactively contacted by a nurse navigator to discuss eligibility and prescreening. Eligible and willing patients were referred to their primary care physician.

Results: In the retrospective phase, of 451 current/former smokers, 184 (40.8%) were eligible for LDCT, 104 (23.1%) were ineligible, and 163 (36.1%) had an incomplete smoking history. Of those eligible, 34 (18.5%) had LDCT ordered. In the prospective phase, 189 (41.9%) were eligible for LDCT (150 [79.4%] of whom had no prior LDCT or diagnostic CT), 106 (23.5%) were ineligible, and 156 (34.6%) had an incomplete smoking history. The nurse navigator identified an additional 56/451 (12.4%) patients as eligible after contacting patients with incomplete smoking history. In total, 206 patients (45.7%) were eligible, an increase of 37.3% compared with the retrospective phase (150). Of these, 122 (59.2%) verbally agreed to screening, 94 (45.6%) met with their physician, and 42 (20.4%) were prescribed LDCT.

Conclusions: A proactive education/recruitment model increased eligible patients for LDCT by 37.3%. Proactive identification/education of patients desiring to pursue LDCT was 59.2%. It is essential to identify strategies that will increase and deliver LDCT screening among eligible and willing patients.

Keywords: low-dose computed tomography; lung cancer screening; nurse navigator; patient identification.

© 2023 Annals of Family Medicine, Inc.

PubMed Disclaimer

Figures

Figure 1.

Retrospective assessment of patients for…

Figure 1.

Retrospective assessment of patients for LDCT screening. LDCT = low-dose computed tomography.

Figure 1.

Retrospective assessment of patients for LDCT screening. LDCT = low-dose computed tomography.

Figure 2.

Prospective proactive patient identification/education guided…

Figure 2.

Prospective proactive patient identification/education guided by nurse navigator for LDCT screening. COVID-19 =…

Figure 2.

Prospective proactive patient identification/education guided by nurse navigator for LDCT screening. COVID-19 = coronavirus disease 2019; CT = computed tomography; LDCT = low-dose computed tomography; PCP = primary care physician.

Figure 2.

Prospective proactive patient identification/education guided…

Figure 2.

Prospective proactive patient identification/education guided by nurse navigator for LDCT screening. COVID-19 =…

Figure 2.

Prospective proactive patient identification/education guided by nurse navigator for LDCT screening. COVID-19 = coronavirus disease 2019; CT = computed tomography; LDCT = low-dose computed tomography; PCP = primary care physician.

Similar articles Cited by References
    1. Siegel RL, Miller KD, Fuchs HE, Jemal A.. Cancer statistics, 2021. CA Cancer J Clin. 2021; 71(1): 7-33. 10.3322/caac.21654 - DOI - PubMed
    1. Aberle DR, Adams AM, Berg CD, et al. ; National Lung Screening Trial Research Team . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5): 395-409. 10.1056/NEJMoa1102873 - DOI - PMC - PubMed
    1. Jemal A, Fedewa SA.. Lung cancer screening with low-dose computed tomography in the United States-2010 to 2015. JAMA Oncol. 2017; 3(9): 1278-1281. 10.1001/jamaoncol.2016.6416 - DOI - PMC - PubMed
    1. Jensen TS, Chin J, Ashby L, Hermansen J, Hutter JD.. Screening for lung cancer with low dose computed tomography (LDCT). Report No. CAG-00439N. Centers for Medicare nd Medicaid Services. Published Feb 5, 2015. Accessed Jan 5, 2023. https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo...
    1. Pham D, Bhandari S, Pinkston C, Oechsli M, Kloecker G.. Lung cancer screening registry reveals low-dose CT screening remains heavily underutilized. Clin Lung Cancer. 2020; 21(3):e206-e211. 10.1016/j.cllc.2019.09.002 - DOI - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3